Refractive surgery continues to experience tepid demand despite an improving economy; cataract surgery volume was higher than expected.
Conference has raised its profile with packed agenda, popular locations.
Trifocal designs have significant PC-IOL market share in Europe; Alcon adds to the available options with its PanOptix lens.
Surgeons reported excellent results with Calhoun Vision’s Light-Adjustable Lens.
Sessions provided mixed data on technology, as most surgeons remain undecided.
At least four devices are in various stages of development; CAPSULaser says it plans to launch its system in late 2015.
The Glaukos iStent was a common topic, though the US remains its center of popularity; other MIGS devices are getting closer to commercialization.
At least 12 papers discussed the four inlays currently commercialized; AcuFocus reported that more than 40 US ophthalmologists are now offering the KAMRA.
OCT angiography devices allow visibility of blood flow with significantly more precision.
Terms of the deal include $300 million up front, plus milestone payments related to AqueSys' lead development programs.
Valeant will pay $6.50 per Synergetics share, a 48 percent premium to the stock’s closing price on Sept. 1.
Sun Pharma was the third suitor seeking to acquire InSite, stepping into the process Sept. 3.
Advanced Technology Glaucoma Surgery devices expected to drive future market growth.
Segment is forecast to climb to $16.5 billion by 2020 at a CAGR of 12 percent.
Demographics of racing enthusiasts match up well with target market for refractive surgery.
Google is collaborating on development of the lens under an agreement with Novartis’ Alcon division.
Many practices have moved in this direction to offset declines in Medicare reimbursement.
The technology accelerator is a partnership between the federal government, New York, and a coalition of universities, nonprofits, industry, and other states.
Ophthalmologists receive average compensation of $292,000 annually, according to Medscape’s 2015 Physician Compensation Report.
You are not currently logged in.
©2018 Market Scope
Lost your Password